by Team Small News | Sep 14, 2025 | Aurobindo Pharma, Biocon, Cipla, Glenmark, Lupin, Mankind, Pharma, Sun Pharma, Torrent Pharma, Zydus
The pharmaceutical industry is complex, with various segments such as innovator products, generics, branded generics, and API. Indian companies are making headway globally, and understanding the industry’s intricacies is crucial for those seeking opportunities....
by Team Small News | Sep 2, 2025 | Pharma, Sun Pharma, Torrent Pharma, Zydus
Gujarat is playing a vital role in India’s pharmaceutical industry, driven by government initiatives and investment opportunities. The state is home to major pharmaceutical companies such as Sun Pharma, Zydus Cadila, and Intas Pharmaceuticals, contributing...
by Team Small News | Jun 1, 2025 | Lupin, Pharma, Sun Pharma, Torrent Pharma
India’s largest pharmaceutical companies, such as Sun Pharmaceutical Industries Ltd and Torrent Pharmaceuticals Ltd, are preparing the next generation of their promoter families to take over the reins. Recently, Torrent Pharma announced the appointment of Aman...
by Team Small News | May 20, 2025 | Pharma, Torrent Pharma, Zydus
Several Indian companies are set to announce their fourth-quarter results on Tuesday, including Hindalco Industries Ltd., Dixon Technologies (India) Ltd., Zydus Lifesciences Ltd., and Torrent Pharmaceuticals Ltd. According to consensus analysts’ estimates...
by Team Small News | May 19, 2025 | Pharma, Torrent Pharma, Zydus
In 2020, the NITI Aayog recommended that state governments hand over the management of public hospitals to private players. However, the Gujarat government had already taken this step in 2009, when it privatized the Bhuj Civil Hospital, which was rebuilt after the...
by Team Small News | Apr 1, 2025 | Aurobindo Pharma, Divi's Laboratories, Pharma, Sun Pharma, Torrent Pharma, Zydus
Citibank has analyzed the potential impact of US tariffs on Indian pharmaceutical companies and has assigned a low probability to such an event. The brokerage firm simulated a 10% tariff scenario and found that companies with a high exposure to US generics, such as...